Merck & Co. might consider settling some lawsuits over its painkiller Vioxx, whose links to heart trouble have spawned thousands of lawsuits and a $253 million jury verdict, a spokesman for the company’s legal team said Friday.
The company has previously said it would fight all personal-injury litigation over the drug’s harmful side effects.
“Certainly we will make reasonable decisions about how to proceed in defending each one of those cases,” spokesman Kent Jarrell told The Associated Press, adding that Merck has “no intention of entering into any kind of global settlement.”
Merck’s general counsel, Kenneth C. Frazier, told The New York Times in Friday’s editions that Merck would consider settling suits brought by people who took Vioxx for long periods of time and had few other risk factors for heart disease.
New Jersey-based Merck pulled Vioxx from the market nearly a year ago when a study showed it could double the risk of heart attack or stroke if taken for 18 months or longer.
Lawyers involved in a Vioxx case in federal court in New Orleans said at a hearing Thursday that nearly 5,000 lawsuits have been filed against Merck, and the number is growing. A trial starts in New Jersey state court next month, followed by the federal case in New Orleans in November.
A jury in Texas last week awarded $253.4 million in damages to the widow of Bob Ernst, who died in 2001 of irregular heart beat, or arrhythmia, after taking Vioxx for eight months.
The bulk of the verdict, $229 million, was punitive damages, which are capped under Texas law. After the caps are applied, the award won’t exceed $26.1 million.
Need Legal Help?
New York City, Long Island, New Jersey, and Florida
Our personal injury attorneys NY are here to help you when you need it the most.